Guanyi Zhang

753 citations
18 papers · 592 indexed · h-index 11

Guanyi Zhang

17 papers receiving 585 citations

Peers

Guanyi Zhang
Comparison fields: 5 of 74
  • Endocrinology, Diabetes and Metabolism 166
  • Pulmonary and Respiratory Medicine 278
  • Cancer Research 99
  • Bioengineering 24
  • Molecular Biology 249
Replace Wen‐Chang Wang with:
Wen‐Chang Wang Taiwan
Yu Wen China
Baolong Su United States
Wenjuan Wu China
Eun Kyung Jang South Korea
Marlena Godlewska Poland
Shintaro Saito Japan
Sergio Piñeiro‐Hermida Spain
Li Ren China
Guanyi Zhang relative to Wen‐Chang Wang Taiwan Wen‐Chang Wang's profile →
Citations per field
00.5×10×20×30×43×
Wen‐Chang Wang · 1×
Citations per year

Countries citing papers authored by Guanyi Zhang

Since Specialization
Citations

This map shows the geographic impact of Guanyi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanyi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanyi Zhang more than expected).

Fields of papers citing papers by Guanyi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanyi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanyi Zhang. The network helps show where Guanyi Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Guanyi Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guanyi Zhang Line = papers co-authored together Guanyi Zhang links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 20250
2 20245
3 20241
4 202419
5 202427
6 202320
7 20232
8 20223
9 202216
10 20215
11 201823
12 201655
13 2016131
14 201637
15 20152
16 201574
17 2014160
18
Splicing variants of androgen receptor in prostate cancer.
201312

About Guanyi Zhang

Guanyi Zhang is a scholar working on Bioengineering, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 592 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Ubiquitin and proteasome pathways (4 papers), Gas Sensing Nanomaterials and Sensors (3 papers), Fungal Infections and Studies (3 papers), Analytical Chemistry and Sensors (3 papers), Antifungal resistance and susceptibility (2 papers), Hormonal and reproductive studies (2 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (166 citations), Pulmonary and Respiratory Medicine (278 citations) and Cancer Research (99 citations). Guanyi Zhang has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Yanfeng Qi, Yan Dong, Oliver Sartor, Xueqi Fu, Xavier Álvarez, Zhan Yang, Haitao Zhang, Stephen R. Plymate, Haitao Zhang and Bo Cao. Their work appears in journals such as Oncotarget, Molecular Cancer Research, Cell Metabolism, Food Chemistry and Sensors and Actuators B Chemical.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026